The AHEAD Study for Pre-Clinical Alzheimer’s Disease
Lay Description
This study investigates whether an experimental medication is effective in slowing the progression of preclinical Alzheimer’s Disease in individuals with mild symptoms with or without a family history of AD.
Category
- Healthy Subjects Needed
- Aging and Geriatric
- Diagnostic
- Family Health
- Nervous System
- IRB Number
- 20200461HU
- NCT Number
- ct.gov registration not required
- Open to Enrollment
- Yes
Eligibility
- Eligible Ages
- Between 55 and 80
- Eligible Genders
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
Participants must have a study partner who is willing to provide information about the individual’s daily activities. ???????
Exclusion Criteria
Recent history of stroke, seizures, or major psychiatric illness. Inability to complete MRI scans.
Study Design
Arm Groups
Study Contact
Floyd Jones
+1 (210) 450-3158
jonesfa@uthscsa.edu
Haritha Vardhini Katragadda
(210) 450-8437
katragaddah@uthscsa.edu
Floyd Jones
+1 (210) 450-3158
jonesfa@uthscsa.edu
Haritha Vardhini Katragadda
(210) 450-8437
katragaddah@uthscsa.edu
Arash Salardini
(210) 450-8437
salardini@uthscsa.edu
Principal Investigator
Arash Salardini